These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 30006781

  • 1. miR-9 inhibits the metastatic ability of hepatocellular carcinoma via targeting beta galactoside alpha-2,6-sialyltransferase 1.
    Han Y, Liu Y, Fu X, Zhang Q, Huang H, Zhang C, Li W, Zhang J.
    J Physiol Biochem; 2018 Aug; 74(3):491-501. PubMed ID: 30006781
    [Abstract] [Full Text] [Related]

  • 2. ST6GAL1 inhibits metastasis of hepatocellular carcinoma via modulating sialylation of MCAM on cell surface.
    Zou X, Lu J, Deng Y, Liu Q, Yan X, Cui Y, Xiao X, Fang M, Yang F, Sawaki H, Sato T, Tan B, Lu X, Feng B, Kuno A, Narimatsu H, Gao C, Zhang Y.
    Oncogene; 2023 Feb; 42(7):516-529. PubMed ID: 36528750
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Caveolin-1 up-regulates integrin α2,6-sialylation to promote integrin α5β1-dependent hepatocarcinoma cell adhesion.
    Yu S, Fan J, Liu L, Zhang L, Wang S, Zhang J.
    FEBS Lett; 2013 Mar 18; 587(6):782-7. PubMed ID: 23416306
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Circ_0015756 promotes proliferation, invasion and migration by microRNA-7-dependent inhibition of FAK in hepatocellular carcinoma.
    Liu L, Yang X, Li NF, Lin L, Luo H.
    Cell Cycle; 2019 Nov 18; 18(21):2939-2953. PubMed ID: 31522588
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. miR-709 up-regulated in hepatocellular carcinoma, promotes proliferation and invasion by targeting GPC5.
    Liu T, Zhang X, Sha K, Liu X, Zhang L, Wang B.
    Cell Prolif; 2015 Jun 18; 48(3):330-7. PubMed ID: 25818666
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
    Lou W, Chen J, Ding B, Chen D, Zheng H, Jiang D, Xu L, Bao C, Cao G, Fan W.
    J Transl Med; 2018 Sep 29; 16(1):266. PubMed ID: 30268144
    [Abstract] [Full Text] [Related]

  • 13. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.
    Wang R, Yu Z, Chen F, Xu H, Shen S, Chen W, Chen L, Su Q, Zhang L, Bi J, Zeng W, Li W, Huang X, Wang Q.
    Biomed Pharmacother; 2018 Jul 29; 103():1632-1642. PubMed ID: 29864952
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. MicroRNA-379-5p inhibits tumor invasion and metastasis by targeting FAK/AKT signaling in hepatocellular carcinoma.
    Chen JS, Li HS, Huang JQ, Dong SH, Huang ZJ, Yi W, Zhan GF, Feng JT, Sun JC, Huang XH.
    Cancer Lett; 2016 May 28; 375(1):73-83. PubMed ID: 26944318
    [Abstract] [Full Text] [Related]

  • 17. MicroRNA-504 functions as a tumor suppressor in hepatocellular carcinoma through inhibiting Frizzled-7-mediated-Wnt/β-catenin signaling.
    Quan H, Li B, Yang J.
    Biomed Pharmacother; 2018 Nov 28; 107():754-762. PubMed ID: 30142536
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.